Search
All
Rapidly advancing understanding of the relationship between humans
and their symbiotic microbes, and how their imbalance (dysbiosis) triggers or contributes to...
Botfuel, an enterprise-ready chatbot platform, announced its recent financing round of €1.3M, led by Seventure Partners’ Seed Funds Quadrivium 1, with participation from...
Seventure Partners, one of Europe’s leaders in financing innovation, and a world-leader in the venture investment in the microbiome sector, today announces that from its...
Enterome SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, is pleased to announce the launch of a Phase 1 clinical study with its...
The TF1 group has announced the acquisition of a majority interest in the capital of MinuteBuzz, French millennials’ favourite social platform with 9 million subscribers and...
MaaT Pharma ODYSSEE Study focuses in prevention of dysbiosis complications with autologous fecal microbiota transplantation in Acute Myeloid Leukemia patients undergoing...
Major treatments such as high-dose antibiotic therapies and chemotherapies can lead to serious complications and create a gut microbiota imbalance (formerly called intestinal...
Bristol-Myers Squibb (NYSE: BMY) and Enterome SA (Enterome), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announced that they...
Anytime announces that its latest funding round has raised 5 million Euros. A leading European player in financing innovation, Seventure Partners deployed €4.5 million for...
Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear medicine, announced today that the...
